| RS1597618787 |
CHRNE
|
Health Risk |
Pathogenic |
Congenital myasthenic syndrome 4A, Congenital myasthenic syndrome 4C |
| RS1597618794 |
CHRNE
|
Health Risk |
Likely pathogenic |
Neurodevelopmental delay, Multifocal seizures |
| RS1597618854 |
CHRNE
|
Health Risk |
Pathogenic |
Congenital myasthenic syndrome 4A, Congenital myasthenic syndrome 4A |
| RS1597619440 |
CHRNE
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital myasthenic syndrome 4A, Congenital myasthenic syndrome 4A |
| RS1597619719 |
CTNS
|
Health Risk |
Pathogenic |
Ocular cystinosis, Juvenile nephropathic cystinosis |
| RS1597620368 |
CHRNE
|
Health Risk |
Pathogenic |
Congenital myasthenic syndrome 4A, Congenital myasthenic syndrome 4A |
| RS1597621216 |
CHRNE
|
Health Risk |
Likely pathogenic |
Congenital myasthenic syndrome 4A, Congenital myasthenic syndrome 4A |
| RS1597621353 |
CHRNE
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital myasthenic syndrome 4A, Congenital myasthenic syndrome 4B |
| RS1597621396 |
CHRNE
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital myasthenic syndrome 4A, Congenital myasthenic syndrome |
| RS1597622118 |
CHRNE
|
Health Risk |
Likely pathogenic |
Congenital myasthenic syndrome 4A, Congenital myasthenic syndrome 4B |
| RS1597623670 |
FBN1
|
Health Risk |
Likely pathogenic |
Marfan syndrome, Marfan syndrome |
| RS1597625734 |
FBN1
|
Health Risk |
Pathogenic |
Marfan syndrome, Marfan syndrome |
| RS1597625794 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1597625799 |
NF1
|
Health Risk |
Pathogenic |
— |
| RS1597625887 |
NF1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Cardiovascular phenotype |
| RS1597625982 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1597626026 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1597626031 |
NF1
|
Health Risk |
Pathogenic |
— |
| RS1597626094 |
NF1
|
Health Risk |
Likely pathogenic |
Neurofibromatosis, type 1 |
| RS1597626161 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1597626163 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1597629649 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1597629679 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1597629724 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1597629765 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1597629809 |
NF1
|
Health Risk |
Likely pathogenic |
Neurofibromatosis, type 1 |
| RS1597629813 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurofibromatosis, type 1 |
| RS1597629882 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurofibromatosis, type 1 |
| RS1597629884 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1597629895 |
NF1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Cardiovascular phenotype |
| RS1597631624 |
FBN1
|
Health Risk |
Pathogenic |
8 conditions, 8 conditions |
| RS1597631662 |
FBN1
|
Health Risk |
Pathogenic |
Marfan syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS1597631751 |
FBN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Marfan syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS1597633163 |
FBN1
|
Health Risk |
Pathogenic |
Familial thoracic aortic aneurysm and aortic dissection, Marfan syndrome |
| RS1597633171 |
PMP22
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease, Charcot-Marie-Tooth disease |
| RS1597633183 |
FBN1
|
Health Risk |
Pathogenic |
Marfan syndrome, Marfan syndrome |
| RS1597633219 |
FBN1
|
Health Risk |
Pathogenic |
Marfan syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS1597635528 |
PMP22
|
Health Risk |
Likely pathogenic |
Hereditary liability to pressure palsies, Hereditary liability to pressure palsies |
| RS1597635540 |
PMP22
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease, Charcot-Marie-Tooth disease |
| RS1597635592 |
SPG7
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary spastic paraplegia 7, Hereditary spastic paraplegia 7 |
| RS1597635615 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1597635722 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1597635740 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1597635745 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1597635793 |
NF1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Cardiovascular phenotype |
| RS1597635825 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1597635936 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurofibromatosis, type 1 |
| RS1597636022 |
NF1
|
Health Risk |
risk factor |
Neurofibromatosis, type 1 |
| RS1597638300 |
GP1BA
|
Health Risk |
Likely pathogenic |
Macrothrombocytopenia, Bernard-Soulier syndrome |
| RS1597638379 |
GP1BA
|
Health Risk |
Pathogenic |
Macrothrombocytopenia, Macrothrombocytopenia |
| RS1597638398 |
GP1BA
|
Health Risk |
Conflicting classifications of pathogenicity |
Macrothrombocytopenia, GP1BA-related disorder |
| RS1597638598 |
GP1BA
|
Health Risk |
Pathogenic/Likely pathogenic |
Thrombocytopenia, Bernard-Soulier syndrome |
| RS1597638681 |
GP1BA
|
Health Risk |
Likely pathogenic |
Thrombocytopenia, Thrombocytopenia |
| RS1597638745 |
GP1BA
|
Health Risk |
Likely pathogenic |
Macrothrombocytopenia, Thrombocytopenia |
| RS1597638753 |
GP1BA
|
Health Risk |
Likely pathogenic |
Thrombocytopenia, Thrombocytopenia |
| RS1597639057 |
GP1BA
|
Health Risk |
Likely pathogenic |
Thrombocytopenia, Thrombocytopenia |
| RS1597640885 |
GP1BA
|
Health Risk |
Likely pathogenic |
Bernard Soulier syndrome, Bernard Soulier syndrome |
| RS1597643228 |
GAS8
|
Health Risk |
Likely pathogenic |
Primary ciliary dyskinesia 33, Primary ciliary dyskinesia 33 |
| RS1597643692 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1597643722 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1597643815 |
NF1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Cardiovascular phenotype |
| RS1597647930 |
CTNS
|
Health Risk |
Pathogenic/Likely pathogenic |
Ocular cystinosis, Juvenile nephropathic cystinosis |
| RS1597652265 |
FBN1
|
Health Risk |
Likely pathogenic |
Marfan syndrome, Marfan syndrome |
| RS1597652471 |
FBN1
|
Health Risk |
Pathogenic |
Marfan syndrome, Marfan syndrome |
| RS1597653264 |
SLC13A5
|
Health Risk |
Likely pathogenic |
Epileptic encephalopathy, Epileptic encephalopathy |
| RS1597654770 |
CTNS
|
Health Risk |
Pathogenic/Likely pathogenic |
Ocular cystinosis, Juvenile nephropathic cystinosis |
| RS1597654857 |
CTNS;CTNS-AS1
|
Health Risk |
Likely pathogenic |
Ocular cystinosis, Juvenile nephropathic cystinosis |
| RS1597657030 |
SLC13A5
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 25 |
| RS1597657969 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1597658021 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1597658192 |
NF1
|
Health Risk |
Pathogenic |
Tibial pseudarthrosis, Neurofibromatosis |
| RS1597658505 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1597658661 |
NF1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Cardiovascular phenotype |
| RS1597658664 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1597658676 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1597658684 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1597659694 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurofibromatosis, type 1 |
| RS1597659721 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1597659830 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS1597659879 |
NF1
|
Health Risk |
Pathogenic |
Tibial pseudarthrosis, Neurofibromatosis |
| RS1597659883 |
NF1
|
Health Risk |
Likely pathogenic |
Neurofibromatosis, type 1 |
| RS1597659893 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1597659939 |
NF1
|
Health Risk |
Likely pathogenic |
Cardiovascular phenotype, Hereditary cancer-predisposing syndrome |
| RS1597660090 |
NF1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Cardiovascular phenotype |
| RS1597660915 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Hereditary cancer-predisposing syndrome |
| RS1597660974 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1597661607 |
SPG7
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 7, Hereditary spastic paraplegia 7 |
| RS1597665063 |
SPG7
|
Health Risk |
Likely pathogenic |
Intellectual disability, Spastic ataxia |
| RS1597665080 |
SPG7
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia 7, Hereditary spastic paraplegia 7 |
| RS1597675888 |
RPL13
|
Health Risk |
Pathogenic |
Spondyloepimetaphyseal dysplasia, Isidor-Toutain type |
| RS1597675890 |
RPL13
|
Health Risk |
Pathogenic |
Spondyloepimetaphyseal dysplasia, Isidor-Toutain type |
| RS1597676540 |
RPL13
|
Health Risk |
Conflicting classifications of pathogenicity |
Spondyloepimetaphyseal dysplasia, Spondyloepimetaphyseal dysplasia |
| RS1597676610 |
SLC13A5
|
Health Risk |
Likely pathogenic |
Epileptic encephalopathy, Epileptic encephalopathy |
| RS1597676674 |
SLC13A5
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 25 |
| RS1597677742 |
SLC13A5
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 25 |
| RS1597680816 |
NF1
|
Health Risk |
Pathogenic |
— |
| RS1597680909 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1597680938 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurofibromatosis, type 1 |
| RS1597680978 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1597681200 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |